These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 15378868

  • 21. Repetitive nerve stimulation studies in the Lambert-Eaton myasthenic syndrome.
    Tim RW, Sanders DB.
    Muscle Nerve; 1994 Sep; 17(9):995-1001. PubMed ID: 8065402
    [Abstract] [Full Text] [Related]

  • 22. [Anti-voltage-gated calcium channel antibodies in the Lambert-Eaton myasthenic syndrome].
    Motomura M, Suenaga A, Matsuo H, Tsujihata M, Nagataki S.
    Rinsho Shinkeigaku; 1994 Oct; 34(10):980-4. PubMed ID: 7834958
    [Abstract] [Full Text] [Related]

  • 23. Lambert-eaton myasthenic syndrome in a patient with small-cell lung cancer.
    Wang S, Bruzzi J, Rodriguez-Garza VP, Komaki RR.
    Clin Lung Cancer; 2006 Jan; 7(4):282-4. PubMed ID: 16512985
    [Abstract] [Full Text] [Related]

  • 24. [Lambert-Eaton myasthenic syndrome. Physiopathological aspects and therapeutic modalities].
    Kuntzer T, Steck AJ, Fiorini E, Mirimanoff RO, Regli F.
    Rev Neurol (Paris); 1991 Jan; 147(12):819-24. PubMed ID: 1688363
    [Abstract] [Full Text] [Related]

  • 25. [Paraneoplastic cerebellar degeneration and Lambert-Eaton myasthenic syndrome associated with anti P/Q-type voltage-gated calcium channel antibody in a patient with primary double lung cancer].
    Iwanami M, Odaka M, Nakamura T, Hirata K.
    Brain Nerve; 2009 Sep; 61(9):1083-7. PubMed ID: 19803409
    [Abstract] [Full Text] [Related]

  • 26. [The Lambert-Eaton myasthenic syndrome: a study of 110 Japanese cases].
    Motomura M.
    Rinsho Shinkeigaku; 1999 Dec; 39(12):1237-9. PubMed ID: 10791087
    [Abstract] [Full Text] [Related]

  • 27. [Response to immunoadsorption and steroid therapies in a patient with carcinomatous Lambert-Eaton myasthenia syndrome accompanied by disturbed consciousness].
    Ishikawa S, Takei Y, Tokunaga S, Motomura M, Nakao Y, Hanyu N.
    Rinsho Shinkeigaku; 2000 May; 40(5):459-63. PubMed ID: 11002728
    [Abstract] [Full Text] [Related]

  • 28. SOX1 antibodies are markers of paraneoplastic Lambert-Eaton myasthenic syndrome.
    Sabater L, Titulaer M, Saiz A, Verschuuren J, Güre AO, Graus F.
    Neurology; 2008 Mar 18; 70(12):924-8. PubMed ID: 18032743
    [Abstract] [Full Text] [Related]

  • 29. Paraneoplastic chronic demyelinating neuropathy and Lambert-Eaton myasthenic syndrome associated with multiple anti-neural antibodies and small-cell lung cancer.
    Rozsa C, Vincent A, Aranyi Z, Kovacs GG, Komoly S, Illes Z.
    Ideggyogy Sz; 2008 Sep 30; 61(9-10):325-8. PubMed ID: 18841652
    [Abstract] [Full Text] [Related]

  • 30. Lambert-Eaton myasthenic syndrome has a more progressive course in patients with lung cancer.
    Wirtz PW, Wintzen AR, Verschuuren JJ.
    Muscle Nerve; 2005 Aug 30; 32(2):226-9. PubMed ID: 15793845
    [Abstract] [Full Text] [Related]

  • 31. Effect of Lambert-Eaton myasthenic syndrome antibodies on autonomic neurons in the mouse.
    Waterman SA, Lang B, Newsom-Davis J.
    Ann Neurol; 1997 Aug 30; 42(2):147-56. PubMed ID: 9266723
    [Abstract] [Full Text] [Related]

  • 32. Lambert-Eaton syndrome with large-cell neuroendocrine carcinoma of the lung.
    Grommes C, Preston DC, Al-Kadhimi Z, Alshekhlee A.
    Muscle Nerve; 2008 Jun 30; 37(6):786-9. PubMed ID: 18506722
    [Abstract] [Full Text] [Related]

  • 33. Lambert-eaton myasthenic syndrome differential reactivity of tumor versus non-tumor patients to subunits of the voltage-gated calcium channel.
    Pellkofer HL, Armbruster L, Krumbholz M, Titulaer MJ, Verschuuren JJ, Schumm F, Voltz R.
    J Neuroimmunol; 2008 Nov 15; 204(1-2):136-9. PubMed ID: 18809213
    [Abstract] [Full Text] [Related]

  • 34. Favorable response to rituximab in a patient with anti-VGCC-positive Lambert-Eaton myasthenic syndrome and cerebellar dysfunction.
    Pellkofer HL, Voltz R, Kuempfel T.
    Muscle Nerve; 2009 Aug 15; 40(2):305-8. PubMed ID: 19609921
    [Abstract] [Full Text] [Related]

  • 35. [Myasthenia gravis with electrophysiological features of Lambert-Eaton myasthenic syndrome: usefulness of serum autoantibodies assay and neuromuscular junction biopsy].
    Matsumoto R, Motomura M, Yoshimura T, Kohara N, Kato T.
    Rinsho Shinkeigaku; 1999 May 15; 39(5):531-7. PubMed ID: 10424144
    [Abstract] [Full Text] [Related]

  • 36. The association of systemic lupus erythematosus and Lambert-Eaton myasthenic syndrome.
    Deodhar A, Norden J, So Y, Bennett R.
    J Rheumatol; 1996 Jul 15; 23(7):1292-4. PubMed ID: 8823710
    [Abstract] [Full Text] [Related]

  • 37. Clinical analysis of 12 Korean Lambert-Eaton myasthenic syndrome (LEMS) patients.
    Moon JS, Sunwoo IN, Kim SM, Lee SA, Cho KH, Park KD, Kim WK, Choi BO, Chun HY.
    Yonsei Med J; 1999 Oct 15; 40(5):454-9. PubMed ID: 10565256
    [Abstract] [Full Text] [Related]

  • 38. Lambert-Eaton myasthenic syndrome in small cell lung cancer: nursing implications.
    Struthers CS.
    Oncol Nurs Forum; 1994 May 15; 21(4):677-83; quiz 684-5. PubMed ID: 8047466
    [Abstract] [Full Text] [Related]

  • 39. [P/Q-type Calcium Channel Antibodies in Lambert-Eaton Myasthenic Syndrome].
    Kitanosono H, Shiraishi H, Motomura M.
    Brain Nerve; 2018 Apr 15; 70(4):341-355. PubMed ID: 29632282
    [Abstract] [Full Text] [Related]

  • 40. Immunocytochemical characteristics of small cell lung carcinoma associated with the Lambert-Eaton myasthenic syndrome.
    Morris CS, Esiri MM, Marx A, Newsom-Davis J.
    Am J Pathol; 1992 Apr 15; 140(4):839-45. PubMed ID: 1314026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.